| NCT ID | NCT06844045 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Icahn School of Medicine at Mount Sinai |
| Condition | Point of Care STI Testing |
| Study Type | INTERVENTIONAL |
| Enrollment | 6,460 participants |
| Start Date | 2026-02-24 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 6,460 participants in total. It began in 2026-02-24 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The proposed research hypothesizes that point-of-care testing (POCT) for sexually transmitted infections (STIs) gonorrhea and chlamydia will be a feasible, acceptable, and appropriate implementation strategy for improving HIV testing and Pre-exposure prophylaxis (PrEP) delivery in youth, by increasing opportunities for clinician-patient counseling, decreasing loss to follow up, and allowing for same-day HIV prevention service provision. This hypothesis will be tested in a pragmatic non-randomized trial comparing clinical (HIV testing and PrEP counseling and prescription) and implementation (feasibility, acceptability, and appropriateness) outcomes between adolescents receiving POCT compared to laboratory-based testing at three clinics within a large pediatric health system.
Eligibility Criteria
Inclusion Criteria: \- Patients age 16-24 years receiving POCT or lab-based GC/CT testing Exclusion Criteria: \- Patients with known HIV or active PrEP prescriptions.
Contact & Investigator
Sarah Wood, MD, MSHP
PRINCIPAL INVESTIGATOR
Mount Sinai Adolescent Health Center
Frequently Asked Questions
Who can join the NCT06844045 clinical trial?
This trial is open to participants of all sexes, aged 16 Years or older, up to 24 Years, studying Point of Care STI Testing. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06844045 currently recruiting?
Yes, NCT06844045 is actively recruiting participants. Contact the research team at naomi.pressman@mountsinai.org for enrollment information.
Where is the NCT06844045 trial being conducted?
This trial is being conducted at Philadelphia, United States.
Who is sponsoring the NCT06844045 clinical trial?
NCT06844045 is sponsored by Icahn School of Medicine at Mount Sinai. The principal investigator is Sarah Wood, MD, MSHP at Mount Sinai Adolescent Health Center. The trial plans to enroll 6,460 participants.